ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1315

Relation of MRI-detected Structural Damage in the Patellofemoral Joint to Pain and Performance Based Function: The MOST Study

Jessica Maxwell1, Tuhina Neogi 2, Kay Crossley 3, Erin Macri 4, Daniel White 5, Ali Guermazi 6, Frank Roemer 7, Michael Nevitt 8, Beth Lewis 9, James Torner 10 and Joshua Stefanik 11, 1Northeastern University, Boston, MA, 2Boston University School of Medicine, Boston, MA, 3La Trobe University, Victoria, Australia, 4Erasmus MC, Rotterdam, Netherlands, 5University of Delaware, Newark, DE, 6Boston Medical Center, Boston, 7University of Erlangen-Nuremberg, Erlangen, Germany, 8University of California at San Francisco, San Francisco, CA, 9University of Alabama at Birmingham, Birmingham, AL, 10University of Iowa at Iowa City, Iowa City, 11Northeastern University, Boston

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: joint damage and MRI, Knee, Osteoarthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 11, 2019

Title: Osteoarthritis – Clinical Poster I

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Osteoarthritis (OA) of the knee is one of the most common causes of disability in the U.S. Often overlooked, OA specific to the patellofemoral joint of the knee (PFJ OA) is highly prevalent, and often occurs in isolation from tibiofemoral (TFJ) OA. While MRI-detected structural damage in the PFJ are related to the development of TFJ lesions, little is known about the clinical significance of these lesions, or the impact of cumulative tissue damage across the four subregions of the PFJ (medial/lateral patella and trochlea). The purpose of this study is to determine the cross-sectional relationship of the number of PFJ subregions with structural MRI-defined tissue damage with knee pain, performance-based function, and physical activity in people with or at high risk of knee OA.   

Methods: We performed a cross-sectional analysis using 60-month data from the NIH-funded Multicenter Osteoarthritis Study. OA features in the four PFJ subregions were scored semi-quantitatively using the WORMS method by two musculoskeletal radiologists. We created a 3 level exposure variable for the number of PFJ subregions with structural damage: (0, 1 or 2,  3 or 4). Three different MRI features were assessed separately: full-thickness cartilage damage (WORMS 2.5, 5-6), bone marrow lesions (BMLs) (≥1), and definite osteophytes (≥2) in the PFJ.  Relation of number of PFJ subregions to knee pain severity (VAS pain) and repeated chair stand time was assessed using ANCOVA. Relation of the odds of at least mild pain with stairs (WOMAC pain scale) and walking < 6,000 steps/day (a level of physical activity associated with risk of incident functional limitation) was assessed using logistic regression. Separate models were created for each PFJ MRI feature. Each analysis was adjusted for age, sex, BMI, previous knee injury/surgery, and coincident TFJ MRI feature.

Results: 1099 knees had complete MRI WORMS readings and performance based function assessed at the 60-month visit. The mean (SD), age and BMI of this sample was 66.8 (7.5) and 29.6 (4.8), respectively; 65% were female. In general, a higher number of PFJ subregions with any MRI-defined structural damage were associated with higher pain levels and longer time to complete 5 chair stands than those with fewer subregions affected (Table 1). Participants with full-thickness cartilage damage or BMLs in 3 or 4 compartments had three times the odds of pain on climbing stairs (Table 2). Participants with full-thickness cartilage damage in at least three compartments or osteophytes in at least one compartment have 2.3 and 2.1 times the odds of walking < 6,000 steps/day (Table 2).

Conclusion: Having damage in multiple subregions of the PFJ is associated with increased pain, decreased function, and greater odds of walking < 6,000 steps/day. The specific outcomes affected depended on the type of tissue damage, with full-thickness cartilage damage appearing to have the most impact across all outcomes. In addition to cartilage damage, osteophytes are associated with walking less steps/day, and BMLs with pain on stair climbing.


Maxwell et al PF OA MRI table

Clinical outcomes for number of PFJ Subregions with MRI-detected structural damage


Disclosure: J. Maxwell, None; T. Neogi, MerckSerono, 5, Novartis, 5; K. Crossley, None; E. Macri, None; D. White, None; A. Guermazi, AstraZeneca, 5, BICL, 1, Boston Imaging Core Lab (BICL), 1, Galapagos, 5, MerckSerono, 5, Pfizer, 5, Roche, 5, Shareholder BICL,LLC, 1, TissueGene, 5; F. Roemer, BICL, 1, Boston Imaging Core Lab, 1, 6, Shareholder BICL,LLC, 1; M. Nevitt, None; B. Lewis, None; J. Torner, None; J. Stefanik, None.

To cite this abstract in AMA style:

Maxwell J, Neogi T, Crossley K, Macri E, White D, Guermazi A, Roemer F, Nevitt M, Lewis B, Torner J, Stefanik J. Relation of MRI-detected Structural Damage in the Patellofemoral Joint to Pain and Performance Based Function: The MOST Study [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/relation-of-mri-detected-structural-damage-in-the-patellofemoral-joint-to-pain-and-performance-based-function-the-most-study/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/relation-of-mri-detected-structural-damage-in-the-patellofemoral-joint-to-pain-and-performance-based-function-the-most-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology